Women's choice for Down's screening-A comparative experience in three district general hospitals

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 146, Issue 1, 2009, Pages 61-64

  Shantha, Narasimhan ^b   Granger, Kath ^a   Arora, Puneet ^b   Polson, David ^b  

^a UNIVERSITY HOSPITALS OF MORECAMBE BAY NHS FOUNDATION TRUST   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Down's syndrome screening; Women's choice

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOWN SYNDROME; FEMALE; GENERAL HOSPITAL; HUMAN; KNOWLEDGE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING;

EID: 68349141663     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.05.009     Document Type: Article

References (12)

1. Wald N.J., Kennard A., Densem J.W., Cuckle H.S., Chard T., and Butler L. Antenatal maternal serum screening for Down's syndrome results of a demonstration project. Br Med J 305 (1992) 391-394
2. CMO's update Number October 31, 2001; Down syndrome screening.
3. Spencer K., Spencer C.E., Power M., Moakes A., and Nicolaides K.H. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol 107 (2000) 1271-1275
4. Gidiri M., McFarlane J., Holding S., and Lindow S.W. Maternal serum screening for Down syndrome: are women's perception changing?. Br J Obstet Gynaecol 114 (2007) 458-461
5. Kuppermann M., Learman L.A., Gates E., et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 107 5 (2006) 1087-1097
6. Department of Health. Model of best practice for providing screening services 2003; Accessed December 19, 2006.
7. Wald N.J., Rodeck C., Hackshaw A.K., Walters J., Chitty L., and Mackinson A.M. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). Health Technol Assess 7 1 (2003) 1-77
8. Dormandy E., Michie S., Hooper R., and Marteau T.M. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices. Int J Epidemiol 34 2 (2005) 346-352
9. Michie S., Dormandy E., and Marteau T.M. Informed choice: understanding knowledge in the context of screening uptake. Patient Educ Counsel (2003) 1-7
10. Marteau T.M., Dormandy E., and Michie S. A measure of informed choice. Health Expect 4 (2001) 99-108 [cross ref]
11. Muller M.A., Bleker O.P., Bonsel G.J., and Bilardo C.M. Women's opinions on the offer and use of Nuchal translucency screening for Down syndrome. Prenat Diagn 26 2 (2006) 1097-1223
12. National Down's Syndrome Screening Programme for England. Antenatal Screening-Working Standards. London: NHS; 2004.